|
|
Volumn , Issue , 2013, Pages
|
|
The economics of new drugs: can we afford to make progress in a common disease?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANIMAL;
COMMERCIAL PHENOMENA;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HUMAN;
MASS COMMUNICATION;
PERSONALIZED MEDICINE;
ANIMALS;
COMMERCE;
COST-BENEFIT ANALYSIS;
DIFFUSION OF INNOVATION;
DRUG COSTS;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
INDIVIDUALIZED MEDICINE;
MARKETING OF HEALTH SERVICES;
|
|
EID: 84946217664
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e126 Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|